Magazine Article | October 1, 2015

Genentech Pushes The Clinical Trial Envelope

Source: Life Science Leader

By Ed Miseta, Chief Editor, Clinical Leader
Follow Me On Twitter @EdClinical

Having spent more than 11 years at Genentech, Joling Mew has heard a lot of industry discussion about patient-centric trials. Mew is development excellence leader in product development and also works closely with the Strategic Innovation Group. Her responsibilities include leading cross-functional, strategic business initiatives with the goal of driving innovations that will transform the drug development process. In response to the patient-centric buzz, Genentech is testing a new model for clinical trials. And Mew believes it has the potential to transform future studies.